Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0187


Assessing resistance to neoadjuvant treatment for breast cancer.

Eleftheria Ignatiadou, MD.

Affiliation: Dr. Eleftheria Ignatiadou, Department of Surgery, University Hospital of Ioannina, Ioannina, TK 45110, Greece.


Since there is no abstract available we provide the first paragraph.

Some patients do not respond to neoadjuvant treatment. Early identification of these patients is crucial for changing treatment strategy and can benefit these patients. But how can we detect the non-responder patients?

(Citation: Gastric & Breast Cancer 2011; 10 (4) 226-228).

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 9 September 2011